Screener
Integra LifeSciences IART Tissue Reconstruction — Cost of goods sold
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Dollars in thousands | Three Months Ended June 30, 2026 / Specialty Surgery | Three Months Ended June 30, 2026 / Tissue Reconstruction | Three Months Ended June 30, 2026 / Corporate and Other | Three Months Ended June 30, 2026 / Total | Six Months Ended June 30, 2026 / Specialty Surgery | Six Months Ended June 30, 2026 / Tissue Reconstruction | Six Months Ended June 30, 2026 / Corporate and Other | Six Months Ended June 30, 2026 / Total |
|---|---|---|---|---|---|---|---|---|
| Total revenue, net | $309,269 | $109,492 | — | $418,761 | $592,404 | $218,275 | — | $810,679 |
| Cost of goods sold | 130,212 | 41,989 | 26,816 | 199,017 | 240,687 | 79,448 | 53,818 | 373,953 |
| Research and development | 14,200 | 8,169 | 1,884 | 24,253 | 26,053 | 15,701 | 6,000 | 47,754 |
| Selling, general & administrative | 75,983 | 40,394 | 56,059 | 172,436 | 153,664 | 83,920 | 113,087 | 350,671 |
| Intangible asset amortization | — | — | 3,770 | 3,770 | — | — | 7,546 | 7,546 |
| Total cost and expenses | 220,395 | 90,552 | 88,529 | 399,476 | 420,404 | 179,069 | 180,451 | 779,924 |
| Operating income (loss) | 88,874 | 18,940 | (88,529) | 19,285 | 172,000 | 39,206 | (180,451) | 30,755 |
| Interest income | 4,267 | 8,372 |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's tissue reconstruction — cost of goods sold?
- Integra LifeSciences (IART) reported tissue reconstruction — cost of goods sold of $41.99M in Q2 2026.
- What does tissue reconstruction — cost of goods sold mean?
- This represents the direct costs attributable to the production and manufacturing of products within the Tissue Reconstruction segment. Monitoring this metric is essential for evaluating the segment's gross margin efficiency and production cost management.
Ask your AI about Integra LifeSciences's tissue reconstruction — cost of goods sold.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude